Posts By: pharmanewsdaily

Construction begins on Merck Biotech Development Center in Switzerland

Merck has broken ground on the €250 million Merck Biotech Development Center, a new biotech development facility in Switzerland at Corsier-sur-Vevey. The new facility will be used for biotech development and manufacturing for clinical studies. Construction on the biotech development facility is likely to be wrapped up next year with full operations to begin by […]

Wuhan coronavirus : AirPHX non-thermal plasma technology to protect from deadly virus

AirPHX said that an independent testing lab has confirmed that its non-thermal plasma technology is highly effective in protecting people from potential exposure to the Wuhan coronavirus or novel coronavirus (2019-nCoV). The technology from airPHX can be scaled for the treatment of air and surfaces in large facilities like hospitals, hotels, airports, schools, and other […]

Sorrento Therapeutics turns down $993m takeover bid from private equity firm

Sorrento Therapeutics, a California-based biopharma company, has turned down a takeover bid worth about $993 million from an undisclosed private equity fund, as per the latest pharma acquisition news. Earlier this month, the US biopharma company was offered $7.00 per share for the acquisition of a majority stake or 100% in the former. Sorrento Therapeutics […]

Allergan to sell brazikumab to AstraZeneca and Zenpep to Nestle

Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma acquisition news. Financial details of the two deals have not been disclosed. The divestments are being taken up in an effort to wrap up the $63 billion AbbVie acquisition of […]

Nano Pulse Stimulation, bioelectric stimulation can treat skin lesions

According to a new study published in the special issue of the journal Bioelectricity, most of the human diseases including skin lesions can be treated by applying bioelectrical impulses. The Nano-Pulse Stimulation (NPS) technique works by delivering nanosecond pulsed electric fields to cells and tissues. NPS specifically targets cells to generate nanometer wide pores and […]

TenNor Therapeutics gets FDA orphan drug status for TNP-2092 in prosthetic joint infections

TenNor Therapeutics has secured orphan drug designation from the US Food and Drug Administration (FDA) for its multitargeting drug conjugate TNP-2092 for the treatment of prosthetic joint infections. According to the Chinese biopharma company, biofilm infections associated with prosthetic joints, central venous catheters, artificial heart valves, and other medical devices has become a huge challenge. […]

Scroll To Top